Stock Market Today, April 29: KalVista Pharmaceuticals Surges on Chiesi Group Acquisition Announcement

On April 29, 2026, a rare-disease deal reshapes biotech M&A expectations as investors weigh tender terms.
Open original source
On April 29, 2026, a rare-disease deal reshapes biotech M&A expectations as investors weigh tender terms.
Open original source